US · RSSS · SOFTWARE - APPLICATION
Research Solutions, Inc. (RSSS) intrinsic value and stock valuation
$2.15as of 2026-11-21 · Mkt cap 73.92M
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Research Solutions, Inc. DCF and intrinsic value
InvestorsCraft values RSSS with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from RSSS’s statements →
Research Solutions, Inc. Graham Number
Graham Number: $0.65d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →
How the business is doing
Fiscal 2011–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $49.1M | $44.6M | $37.7M | $32.9M | $31.8M |
| Operating income | $2.5M | -$-770K | $240K | -$-1.63M | -$-280K |
| Net income | $1.27M | -$-3.79M | $570K | -$-1.63M | -$-290K |
| EPSd | $41.4K | -$-131.32K | $19.6K | -$-61.7K | -$-11.15K |
| Operating cash flow | $7.02M | $3.55M | $3.38M | -$-420K | $1.87M |
| Capital expenditure | -$-20K | -$-70K | -$-50K | -$-40K | -$-20K |
| Free cash flow | $7M | $3.48M | $3.34M | -$-460K | $1.85M |
| Total assets | $46.1M | $41.9M | $21.8M | $17M | $16.9M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net debt | -$-12.23M | -$-6.1M | -$-13.55M | -$-10.6M | -$-11M |
| Total equity | $13.9M | $11.7M | $7.33M | $4.88M | $5.43M |
| Cash and short-term investments | $12.2M | $6.1M | $13.6M | $10.6M | $11M |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $49.1M | $44.6M | $37.7M | $32.9M | $31.8M |
| Cost of revenue | $24.9M | $25M | $23M | $20.9M | $21.5M |
| Gross profit | $24.2M | $19.6M | $14.7M | $12M | $10.3M |
| Research and development expenses | $5.63M | $5.44M | $3.74M | $3.71M | $2.64M |
| Selling, general and administrative expenses | $15M | $14.1M | $10.8M | $9.78M | $7.95M |
| Other expenses | $1.04M | $860K | -$-70K | $160K | -$-20K |
| Operating expenses | $21.7M | $20.4M | $14.5M | $13.7M | $10.6M |
| Cost and expenses | $46.6M | $45.4M | $37.5M | $34.6M | $32M |
| Interest income | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest expense | $0.00 | $0.00 | $0.00 | $140K | $0.00 |
| Depreciation and amortization | $1.25M | $840K | $50K | $20K | $80K |
| Ebitda | $3.54M | $90K | $170K | -$-1.47M | -$-240K |
| Operating income | $2.5M | -$-770K | $240K | -$-1.63M | -$-280K |
| Total other income/expenses, net | -$-1.15M | -$-2.9M | $340K | $10K | $0.00 |
| Income before tax | $1.35M | -$-3.67M | $580K | -$-1.62M | -$-280K |
| Income tax expense | $80K | $110K | $10K | $10K | $0.00 |
| Net income | $1.27M | -$-3.79M | $570K | -$-1.63M | -$-290K |
| Weighted average shares outstanding | $30.7M | $28.9M | $26.9M | $26.4M | $26M |
| Weighted average diluted shares outstanding | $30.7M | $28.9M | $29.1M | $26.4M | $26M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $12.2M | $6.1M | $13.6M | $10.6M | $11M |
| Net receivables | $7.19M | $6.88M | $6.15M | $5.25M | $4.72M |
| Inventory | $0.00 | $0.00 | $1.2M | $0.00 | $0.00 |
| Total current assets | $20M | $14.7M | $21.3M | $17M | $16.9M |
| Property, plant and equipment, net | $60K | $90K | $70K | $50K | $20K |
| Goodwill and intangible assets | $26.1M | $27.1M | $460K | $0.00 | $0.00 |
| Long-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current assets | $26.1M | $27.2M | $530K | $50K | $20K |
| Total assets | $46.1M | $41.9M | $21.8M | $17M | $16.9M |
| Accounts payable | $7.44M | $8.84M | $8.08M | $6.6M | $6.69M |
| Short-term debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Deferred revenue | $10.7M | $9.02M | $6.42M | $5.54M | $4.8M |
| Total current liabilities | $25.5M | $17.9M | $14.5M | $12.1M | $11.5M |
| Long-term debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $6.68M | $12.3M | $0.00 | $0.00 | $0.00 |
| Capital lease obligations | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total liabilities | $32.2M | $30.2M | $14.5M | $12.1M | $11.5M |
| Common stock | $30K | $30K | $30K | $30K | $30K |
| Retained earnings | -$-25.04M | -$-26.31M | -$-22.52M | -$-23.09M | -$-21.46M |
| Accumulated other comprehensive income (loss) | -$-120K | -$-120K | -$-120K | -$-120K | -$-120K |
| Total equity | $13.9M | $11.7M | $7.33M | $4.88M | $5.43M |
| Total investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net debt | -$-12.23M | -$-6.1M | -$-13.55M | -$-10.6M | -$-11M |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | $1.27M | -$-3.79M | $570K | -$-1.63M | -$-290K |
| Depreciation and amortization | $1.25M | $840K | $50K | $20K | $80K |
| Stock-based compensation | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Change in working capital | $1.04M | $1.11M | $840K | $170K | $1.06M |
| Accounts receivable | -$-340K | -$-340K | -$-900K | -$-530K | -$-270K |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Accounts payable | -$-1.43M | $560K | $1.34M | -$-80K | $340K |
| Net cash provided by operating activities | $7.02M | $3.55M | $3.38M | -$-420K | $1.87M |
| Investments in property, plant and equipment | -$-20K | -$-70K | -$-50K | -$-40K | -$-20K |
| Acquisitions, net | $0.00 | -$-10.02M | $0.00 | $0.00 | $0.00 |
| Net cash used for investing activities | -$-20K | -$-10.1M | -$-340K | -$-40K | -$-20K |
| Common stock issued | $180K | $0.00 | $60K | $160K | $0.00 |
| Common stock repurchased | -$-930K | -$-550K | -$-100K | -$-90K | -$-180K |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net cash used for financing activities | -$-880K | -$-910K | -$-100K | $60K | -$-160K |
| Net change in cash | $6.13M | -$-7.45M | $2.94M | -$-400K | $1.69M |
| Cash at end of period | $12.2M | $6.1M | $13.6M | $10.6M | $11M |
| Operating cash flow | $7.02M | $3.55M | $3.38M | -$-420K | $1.87M |
| Capital expenditure | -$-20K | -$-70K | -$-50K | -$-40K | -$-20K |
| Free cash flow | $7M | $3.48M | $3.34M | -$-460K | $1.85M |
Line items
Line items
Line items
About Research Solutions, Inc.
Research Solutions, Inc., through its subsidiaries, provides research cloud-based software-as-a-service software platform and related services to corporate, academic, government and individual researchers in the United States, Europe, and internationally. It provides Discover Tools that facilitates search discovery across virtually all scientific, technical, and medical (STM) articles available, including basic search solutions and advanced search tools comprising Resolute.ai and Scite.ai products, a tools that allows for searching and identifying relevant research and find insights in other datasets adjacent to STM content, such as clinical trial, patent, life science and medtech regulatory information, competitor and technology landscape insights in addition to searching the customer’s internal datasets. The company also offers Article Galaxy and Article Galaxy Scholar, a solution that allows research organizations to load entitlements, including subscriptions, discount, or token packages, and existing library of articles. In addition, it provides Generative AI, a solution to help researchers understand the quality of the articles they are reviewing, speed up the review process, and to understand how various research papers relate to each other. Further, the company offers references solution, enables researchers to organize literature, collaborate with team members, and access collection of scientific content. Additionally, its platform facilitates the sale of published STM content sold as individual articles. The company was formerly known as Derycz Scientific, Inc. and changed its name to Research Solutions, Inc. in March 2013. Research Solutions, Inc. was incorporated in 2006 and is based in Henderson, Nevada.
- CEO
- Roy W. Olivier
- Employees
- 136
- Beta
- 0.73
Explore
Frequently asked questions
What is the intrinsic value of Research Solutions, Inc. (RSSS)?
Research Solutions, Inc. (RSSS) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is RSSS undervalued?
RSSS trades at a price of $2.15 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.